Development Level

Tbio 72 | 11,651
Tchem 7 | 1,388
Tclin 7 | 612
Tdark 5 | 6,593

IMPC Phenotype

increased circulating triglyce... 3 | 42
preweaning lethality, incomple... 3 | 499
abnormal behavior 2 | 298
hypoactivity 2 | 132
increased circulating creatini... 2 | 38
preweaning lethality, complete... 2 | 979
abnormal behavioral response t... 1 | 66
abnormal bone mineralization 1 | 38
abnormal embryo size 1 | 220
abnormal gait 1 | 69
abnormal head morphology 1 | 10
abnormal optic disc morphology 1 | 10
abnormal retinal blood vessel ... 1 | 26
abnormal seminal vesicle morph... 1 | 114
abnormal startle reflex 1 | 15
decreased circulating alkaline... 1 | 46
decreased circulating aspartat... 1 | 34
decreased circulating glucose ... 1 | 126
decreased circulating phosphat... 1 | 27
decreased circulating total pr... 1 | 49
decreased eosinophil cell numb... 1 | 24
decreased fasted circulating g... 1 | 65
decreased prepulse inhibition 1 | 82
embryonic lethality prior to o... 1 | 239
enlarged heart 1 | 210
head bobbing 1 | 5
hyperactivity 1 | 148
increased bone mineral density 1 | 72
increased circulating chloride... 1 | 41
increased circulating sodium l... 1 | 71
increased hematocrit 1 | 46
increased leukocyte cell numbe... 1 | 47
increased mean corpuscular hem... 1 | 96
increased mean corpuscular vol... 1 | 92
increased or absent threshold ... 1 | 101
increased prepulse inhibition 1 | 32
increased startle reflex 1 | 112
increased total body fat amoun... 1 | 134
male infertility 1 | 123
mammalian phenotype 1 | 17
short tibia 1 | 97
tremors 1 | 39

Disease

Carcinoma 79 | 11,493
ovarian cancer 54 | 8,520
osteosarcoma 43 | 7,950
glioblastoma 41 | 5,792
psoriasis 40 | 6,694
ependymoma 35 | 4,679
non-small cell lung cancer 35 | 2,890
Cancer 33 | 2,499
lung cancer 31 | 4,740
Astrocytoma, Pilocytic 29 | 3,081
invasive ductal carcinoma 29 | 2,951
malignant mesothelioma 29 | 3,232
medulloblastoma, large-cell 29 | 6,241
pancreatic cancer 29 | 2,398
atypical teratoid / rhabdoid tumor 28 | 5,112
intraductal papillary-mucinous adenoma (IPMA) 27 | 2,955
Kidney cancer 26 | 2,613
lung carcinoma 26 | 2,843
Breast cancer 25 | 3,578
interstitial cystitis 25 | 2,312
intraductal papillary-mucinous carcinoma (IPMC) 24 | 2,989
adult high grade glioma 23 | 3,801
cystic fibrosis 22 | 1,696
intraductal papillary-mucinous neoplasm (IPMN) 22 | 3,291
lung adenocarcinoma 22 | 2,716
Autosomal recessive predisposition 20 | 1,442
group 3 medulloblastoma 20 | 4,104
tuberculosis 20 | 2,010
ductal carcinoma in situ 18 | 1,745
pituitary cancer 18 | 1,972
pancreatic ductal adenocarcinoma liver metastasis 16 | 1,962
colon cancer 15 | 1,478
primary pancreatic ductal adenocarcinoma 15 | 1,109
Liver Cirrhosis, Experimental 14 | 769
breast carcinoma 14 | 1,638
diabetes mellitus 14 | 1,728
oligodendroglioma 14 | 2,850
subependymal giant cell astrocytoma 14 | 2,287
ulcerative colitis 14 | 1,819
Duchenne muscular dystrophy 13 | 601
Pick disease 13 | 1,894
astrocytic glioma 13 | 2,597
gastric carcinoma 13 | 807
primitive neuroectodermal tumor 13 | 3,035
adrenocortical carcinoma 12 | 1,428
cutaneous lupus erythematosus 12 | 1,057
Atopic dermatitis 11 | 952
astrocytoma 11 | 1,146
dermatomyositis 11 | 966
pediatric high grade glioma 11 | 1,064
sonic hedgehog group medulloblastoma 11 | 467
Kidney disease 10 | 430
autosomal dominant Emery-Dreifuss muscular dystrophy 10 | 510
Atherosclerosis 9 | 291
Rheumatoid arthritis 9 | 1,191
Schizophrenia 9 | 1,160
group 4 medulloblastoma 9 | 1,855
juvenile dermatomyositis 9 | 1,187
nasopharyngeal carcinoma 9 | 1,058
Cerebrovascular disease 8 | 238
Liver cancer 8 | 604
Melanoma 8 | 711
Spontaneous abortion 8 | 113
aldosterone-producing adenoma 8 | 665
Dull intelligence 7 | 645
Intellectual disability 7 | 1,016
Low intelligence 7 | 645
Mental Retardation 7 | 645
Mental deficiency 7 | 645
Poor school performance 7 | 645
Small head 7 | 374
Vascular disease 7 | 319
acute quadriplegic myopathy 7 | 1,158
esophageal adenocarcinoma 7 | 737
mucosa-associated lymphoid tissue lymphoma 7 | 484
nephrosclerosis 7 | 333
primary Sjogren syndrome 7 | 735
Alzheimer's disease 6 | 658
Anemia 6 | 365
Arthritis 6 | 290
Coronary artery disease 6 | 268
Gliosis 6 | 56
Heart disease 6 | 306
Hypersensitivity reaction type II disease 6 | 253
Hypertension 6 | 396
Neoplasm Metastasis 6 | 168
Osteoporosis 6 | 363
Prostatic Neoplasms 6 | 495
Thrombocytopenia 6 | 197
fibroadenoma 6 | 559
head and neck cancer 6 | 271
pancreatic carcinoma 6 | 562
Abortion, Spontaneous 5 | 109
Becker muscular dystrophy 5 | 191
Cognitive delay 5 | 608
Down syndrome 5 | 499
Epilepsy 5 | 792
Hypoplastic mandible condyle 5 | 275
Mental Depression 5 | 333
Mental and motor retardation 5 | 608

Tissue

Digestive Tract 88 | 17,369
Male tissues 88 | 17,142
Female tissues 87 | 17,400
Blood and immune system 86 | 16,909
Endocrine System 86 | 18,159
Respiratory system 86 | 16,393
Skin and soft tissues 86 | 17,230
Liver and Pancreas 85 | 16,750
Urinary Tract 85 | 16,678
Nervous System 82 | 16,725
Cardiovascular System 80 | 15,192

Target Family

Non-IDG 79 | 12,091
Enzyme 7 | 4,145
Transcription Factor 3 | 1,400
Kinase 2 | 634

GO Process

cell-matrix adhesion 91 | 91
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Epithelial membrane protein 2 EMP2 Tbio Non-IDG -2.30856 210.6 116
Integrin alpha-11 ITGA11 Tbio Non-IDG -1.13736 14.3 76
Integrin alpha-2 ITGA2 Tbio Non-IDG -2.58423 335.9 895
Nephronectin NPNT Tbio Non-IDG -1.54450 37.2 104
EMILIN-1 EMILIN1 Tbio Non-IDG -1.54226 36.3 0
Integrin beta-7 ITGB7 Tclin Non-IDG -1.63572 38.4 374
Integrin alpha-3 ITGA3 Tbio Non-IDG -2.08360 104.1 587
T-cell surface protein tactile CD96 Tbio Non-IDG -2.05505 111.7 205
Lymphatic vessel endothelial hyaluronic acid receptor 1 LYVE1 Tbio Non-IDG -2.77184 557.5 586
Mitochondrial import inner membrane translocase subunit Tim10 B TIMM10B Tdark Enzyme 0.11 0.77 53